The prevalence of PSA screening has decreased, particularly among men under the age of 75 years, following the US Preventative Services Task Force (USPSTF) recommendation against screening all men in 2012.
Lowering blood pressure (BP) below recommended targets significantly reduces rates of stroke and myocardial infarction (MI) among high-risk patients, a meta-analysis of almost 45,000 people has found.
Patricia Hall, clinical nurse specialist at the Mater in Dublin, focuses on caring for inner city patients linked to drug treatment centres and homeless services, writes Maureen Browne.
Dr Peter McMahon, Consultant Emergency Radiologist, at the Mater Hospital, Dublin, on the who, which and when of scanning. Maureen Browne reports.
Beginning a two-part review of VTE 2015 in Dublin, Prof Harry Büller, Prof of Medicine, Academic Medical Centre, Amsterdam, spoke about trials for the treatment of patients with DVT and PE, reports Maureen Browne.
Childhood cancer survivors are at heightened risk of a wide range of autoimmune diseases, reveals research published online in the Annals of the Rheumatic Diseases, with diabetes and Addison’s disease making up almost half of the excess cases.
Adding ultrasound to standard mammography tests in breast screening could result in improved rates of detection for breast cancer in women in Japan, according to a new study published in The Lancet.
Shared financial incentives for doctors and patients, but not incentives to physicians or patients alone, resulted in a modest reduction of low-density lipoprotein cholesterol (LDL-C) levels after 12 months, according to a study in the November 10 issue of JAMA.
Exposure to second-hand smoke at four months of age is associated with an increased risk of tooth decay at age three, a new study from Japan has concluded.
Irish scientists have developed a new technique for looking at the initial steps of DNA oxidation — a process that can lead to DNA damage, mutations and cancers. The breakthrough, which uses DNA in crystals, should help related research in the fields of cancer medicine and drug development.